Reddit Posts
Why RADR Could Be Lantern Pharma's Most Undervalued Asset
Lantern Pharma ($LTRN): Why Is the Market Valuing an AI Oncology Platform at Only $50M?
$LTRN, an oncology biotech with AI potential
Lantern Pharma ($LTRN) – Quick Catalyst & Pipeline Overview
Sub $60m Cap - LTRN Pharma (AI play)
AI penny stocks with the ability to fulfil your financial aspirations
Mentions
Yes. The stock performance over the last few years has obviously been disappointing. My interest today is based on the current valuation, the recent LP-300 developments, and the potential commercialization of RADR and withZeta. At roughly a $50M market cap, I believe the market is assigning very little value to those opportunities today. Time will tell whether that thesis is right or wrong.
How about the $RADR pumps? Argh.
This, RADR and ELTP are the 3 most promising plays I've noticed in this sub. Have stake in each one